FDA Approves Recursion's CCM Drug for Phase I Trials!

Announcements of drug trials and other treatment information

FDA Approves Recursion's CCM Drug for Phase I Trials!

Postby Connie Lee » Tue Jul 10, 2018 6:21 pm

BREAKING NEWS: Recursion has received FDA approval to begin clinical studies of a new medication called REC-994 for CCM! They plan to begin Phase I safety trials later this year (healthy volunteers participate to make sure the medication is safe in humans). A great milestone!

Read more here: https://www.prnewswire.com/news-releases/recursion-receives-fda-clearance-of-investigational-new-drug-application-to-initiate-first-clinical-trial-of-rec-994-in-cerebral-cavernous-malformation-300678055.html
Connie Lee
President and CEO, Angioma Alliance
17-year-old daughter with CCM3 mutation who has had 4 brain surgeries, T2-L3 spinal fusion
To support Angioma Alliance, visit http://www.Angioma.org/Donate.
User avatar
Connie Lee
Founder, Angioma Alliance
 
Posts: 440
Joined: Sat Sep 25, 2010 2:41 pm
Location: Norfolk, Virginia

Re: FDA Approves Recursion's CCM Drug for Phase I Trials!

Postby Elizabeth » Thu Jul 12, 2018 4:51 am

Wow!!! Awesome!!! Sounds very promising!!!
Diagnosed September '09 with one CM centered in the right insular cortex/basal ganglia. Saw many, many doctors and had surgery 12/10/10 with Dr. Spetzler. I am thrilled to have this bleeding thing out of my head even though I suffered a stroke during surgery. Have had/ continue to make an amazing recovery. http://www.thankfulforeveryday.blogspot.com
Elizabeth
Moderator
 
Posts: 1644
Joined: Mon Sep 27, 2010 6:49 pm
Location: Los Angeles


Return to Drug Trials

Who is online

Users browsing this forum: No registered users and 1 guest

cron